Fundraising Fox
John Orloff
InvestorVenture Partner at Agent Capital
Find your path to John
Sign up to see every warm intro you have to John
- Paths you didn't know you had: your email and LinkedIn already hold routes to John. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Venture Partner and former EVP and Global Head of R&D at Alexion, where he expanded the pipeline supporting the AstraZeneca acquisition. Previously held R&D leadership roles at Baxalta, Novartis and Merck; holds an MD.
Deals · 2
Zenas BiopharmaBoard seat
via Agent Capital · filed Nov 2022 · $183.9M raise
BenevolentAIBoard seat
via Agent Capital · filed Sep 2022
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Agent Capital
Frequently asked questions
- Who is John Orloff?
- Venture Partner and former EVP and Global Head of R&D at Alexion, where he expanded the pipeline supporting the AstraZeneca acquisition. Previously held R&D leadership roles at Baxalta, Novartis and Merck; holds an MD.
- Where does John Orloff work?
- John Orloff is Venture Partner at Agent Capital.
- What boards does John Orloff sit on?
- John Orloff holds tracked board seats at BenevolentAI, Zenas Biopharma.
About this profile. Compiled from public sources — Agent Capital's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights